The Enrichment, Training, and Outreach Program of the DRTC orchestrates a range of essential DRTC activities that greatly enhance the environment for diabetes research at Vanderbilt. The Vanderbilt DRTC is an active organizer of and participant in local and broad outreach and training efforts. The goals of the DRTC Enrichment, Training and Outreach Program are threefold: 1) To coordinate and provide enrichment activities that enhance the exchange of information and ideas to foster collaboration and advancement in diabetes research;2) To provide support and leadership for training activities that enhance diabetes research both locally and in the broader scientific community;and 3) To coordinate and support outreach efforts to Vanderbilt community, middle Tennessee area and beyond. The Vanderbilt DRTC uses multiple mechanisms to enhance the diabetes research and training environment on the Vanderbilt campus including, a weekly seminar series, an annual Diabetes Research Day, and an annual Diabetes Month with events across the campus. In addition, DRTC-affiliated investigators are associated with three major training grants on campus and direct and teach in multiple courses that are open to the Vanderbilt community and beyond. Substantial resources provided by Vanderbilt University augment the DRTC funds, allowing us to have an even greater impact on campus and in the broader community.

Public Health Relevance

The Enrichment, Training and Outreach component of the DRTC is essential to our mission of high quality diabetes research and improvements in public understanding and public health. The efforts of this program stimulate and support collaborative science, provide mentoring to the next generation of diabetes researchers, and educate the Vanderbilt community and general public about basic research, new treatments and public health issues regarding diabetes and obesity.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
United States
Zip Code
Moore, Mary Courtney; Kelley, David E; Camacho, Raul C et al. (2018) Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts. Diabetes 67:1173-1181
Funkhouser-Jones, Lisa J; van Opstal, Edward J; Sharma, Ananya et al. (2018) The Maternal Effect Gene Wds Controls Wolbachia Titer in Nasonia. Curr Biol 28:1692-1702.e6
Hart, Nathaniel J; Aramandla, Radhika; Poffenberger, Gregory et al. (2018) Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3:
Uddin, Md Imam; Jayagopal, Ashwath; Wong, Alexis et al. (2018) Real-time imaging of VCAM-1 mRNA in TNF-? activated retinal microvascular endothelial cells using antisense hairpin-DNA functionalized gold nanoparticles. Nanomedicine 14:63-71
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Beach, Lauren B; Elasy, Tom A; Gonzales, Gilbert (2018) Prevalence of Self-Reported Diabetes by Sexual Orientation: Results from the 2014 Behavioral Risk Factor Surveillance System. LGBT Health 5:121-130
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Herrick, Mary K; Favela, Kristin M; Simerly, Richard B et al. (2018) Attenuation of diet-induced hypothalamic inflammation following bariatric surgery in female mice. Mol Med 24:56
Horwitz, Elad; Krogvold, Lars; Zhitomirsky, Sophia et al. (2018) ?-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes. Diabetes 67:2305-2318
Perez, Katia M; Curley, Kathleen L; Slaughter, James C et al. (2018) Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism. J Clin Endocrinol Metab 103:4265-4274

Showing the most recent 10 out of 697 publications